When is the next results date for Unichem Laboratories Ltd?
2026-05-07 23:16:45Unichem Laboratories Ltd is scheduled to declare its results on 22 May 2026....
Read More
Unichem Laboratories Ltd is Rated Sell
2026-05-06 10:11:00Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read More
Unichem Laboratories Ltd Surges 8.28% to Day's High of Rs 401.45 — Outperforms Sector by 5.43 Percentage Points
2026-04-29 13:01:02The Sensex advanced 1.35% on 29 Apr 2026, yet Unichem Laboratories Ltd outpaced the broader market with an 8.28% gain, touching an intraday high of Rs 401.45. This 5.43-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read MoreUnichem Laboratories Gains 6.18%: 3 Key Factors Driving the Week’s Rally
2026-04-26 11:00:04Key Events This Week 20 Apr: Stock opens at Rs.345.00, down 1.67% amid flat Sensex 22 Apr: Intraday high surge of 8.84% to Rs.372.10 23 Apr: Continued momentum with 7.0% intraday surge to Rs.392.20 24 Apr: Valuation upgrade signals renewed price attractiveness Week OpenRs.350.85 Week CloseRs.37...
Read More
Unichem Laboratories Ltd is Rated Sell
2026-04-25 10:10:36Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 April 2026, providing investors with the latest insights into its performance and outlook.
Read More
Unichem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-04-24 08:00:12Unichem Laboratories Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, despite ongoing sector headwinds and a challenging price performance relative to the broader market. This recalibration in price-to-earnings and price-to-book value metrics offers investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.
Read More
Unichem Laboratories Ltd Surges 7.0% to Day's High of Rs 392.2 — Outperforms Sector by 0.62 Percentage Points
2026-04-23 11:15:54The Sensex declined 0.91% on 23 Apr 2026 while Unichem Laboratories Ltd surged 7.0%, reaching an intraday high of Rs 392.2. This 0.62 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a stock-specific strength amid a broadly weak market environment.
Read More
Unichem Laboratories Ltd Surges 8.84% to Day's High of Rs 372.1 — Outperforms Sector by 6.97 Percentage Points
2026-04-22 13:15:53The Sensex declined by 0.79% on 22 Apr 2026, yet Unichem Laboratories Ltd surged 8.84%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 7 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine recovery or a technical bounce within a broader downtrend.
Read More
Unichem Laboratories Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-04-16 08:01:25Unichem Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent mild improvement in price momentum, the pharmaceutical company’s stock continues to face headwinds, with its overall technical grade remaining in the sell category. This article analyses the latest technical indicators, price movements, and comparative returns to provide a comprehensive view of Unichem’s current market positioning.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Jun-2026 | Source : BSENotice issued in the newspapers on 16th June 2026 in terms of Circular No. 20/2020 5th May 2020 issued by the Ministry of Corporate Affairs.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Equity Intelligence India Pvt Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Equity Intelligence India Pvt Ltd
Corporate Actions
No Upcoming Board Meetings
Unichem Laboratories Ltd has declared 200% dividend, ex-date: 01 Aug 22
Unichem Laboratories Ltd has announced 2:5 stock split, ex-date: 21 Oct 10
No Bonus history available
No Rights history available